ClinicalTrials.Veeva

Menu

RESTART the Prevention of Pressure Ulcers: Comparing the Effectiveness and Cost of a Reactive Static Air Mattress and Alternating Air Pressure Mattress

V

Vitaz

Status

Enrolling

Conditions

Pressure Ulcer
Pressure Injury
Decubitus Ulcer

Treatments

Device: Reactive static air support surfaces

Study type

Interventional

Funder types

Other

Identifiers

NCT06294327
EC23027

Details and patient eligibility

About

Pressure ulcers are a global issue and substantial concern for healthcare systems. A review of the literature between January 2000 and December 2012 has revealed that prevalence rate of pressure ulcers in aged care facilities were between 4.1% and 32.2%, and the incidence rates ranged from 1.9% to 59%. Similarly, a systematic review reported that the prevalence of pressure ulcer varied between 0.3% and 46%, and the incidence of pressure ulcer ranged from 0.8% to 34%. Most epidemiological data were obtained from hospitals (38.7%) and institutional long-term care facilities (29.7%).

The costs associated with pressure ulcers are considerable. According to the Agency for Healthcare Research & Quality (2011), the US healthcare system has allocated approximately $ 9.1 - $ 11.6 billion annually for the health care cost of pressure ulcer. In addition to direct treatment-related costs, the development of pressure ulcer also results in litigation and government penalties, and affects hospital performance metrics. A systematic review has reported that the cost for treatment of pressure ulcer was higher than its prevention. That is, the cost per patient per day ranged from € 1.71 to € 470.49 (for treatment) and from € 2.65 to € 87.57 (for prevention) across all settings.

This randomized controlled trial will be performed in a general hospital in a random sample of 308 patients (nursing wards geriatric n=3 and orthopedic (n=3)) who are at high risk of developing pressure ulcers. Patients will be included in the study for a period > 2 hospitalisation days. Skin assessment and risk factor registration will be done on a daily base by the ward nurses. Reliability checks and time measurements will be completed by the researcher.

Enrollment

308 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Norton score < 14
  • Bed and/or chairfast
  • no pressure ulcers or at least pressure ulcer category I

Exclusion criteria

  • Norton Score >/=14
  • Pressure ulcers category II, III, IV, deep tissue injury (DTI) or unstageable pressure ulcer
  • Expected length of hospital stay < 2 days
  • Medical contraindication for use of reactive static air support surfaces
  • End of life care (or Do Not Reanimate (DNR) code IV)
  • Age < 18 years

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

308 participants in 2 patient groups

Reactive static air support surfaces (Repose®)
Experimental group
Description:
Intervention with Repose® devices Standard repositioning protocol is applied.
Treatment:
Device: Reactive static air support surfaces
Alternating air pressure mattress (ArjoHuntleigh® Alpha Response)
No Intervention group
Description:
Standard care with mattress type: ArjoHuntleigh® Alpha Response Standard repositioning protocol is applied.

Trial contacts and locations

1

Loading...

Central trial contact

Dimitri Beeckman, Prof.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems